Our Private Equity & Venture Capital practice supports investors, fund managers and businesses in private equity, growth equity and venture capital. With deep industry knowledge, we provide tailored legal solutions to help our clients navigate the complexities of private capital transactions, from initial investment to exit.

Private Equity

We advise on all aspects of private equity, including buyouts, mergers and acquisitions and divestments. Our team has extensive experience assisting Australian and international firms to achieve their investment goals, with expertise in cross-border and leveraged finance experience in the UK and US. Our specialist foreign investment team guides foreign investors through Australia’s complex regulations. Our services include establishing private equity funds, development and expansion, capital investments, MBOs, LBOs, auction sale processes and management incentive plans. We also advise on the privatisation of publicly listed companies and the acquisition of interests in existing private equity fund portfolios. 

Growth Equity

We support growth equity investors and companies in structuring investments for optimal outcomes, with particular expertise in life sciences and technology. We negotiate terms that align with business objectives and protect against dilution.  For companies, we provide counsel on raising capital while ensuring regulatory compliance and we craft agreements that reflect the long-term vision of the business. We ensure that investor rights are adequately protected by advising on veto rights, board representation and exit mechanisms to balance control between founders and investors.

Venture Capital

Our venture capital practice supports investors and companies throughout the investment cycle, from seed rounds to exits. Whether you are an investor seeking to capitalise on the next big innovation or a founder looking to secure strategic funding, we provide the legal insight and strategic advice necessary for success. We have expertise in handling SAFEs, convertible notes and preference shares, whilst ensuring well-defined agreements to protect all parties. We navigate the regulatory landscape and provide guidance on compliance with securities laws, tax regulations and intellectual property protections, to ensure smooth transactions. Our clients include Potentia Capital, EQT, Advent International, Accel-KKR, Level Equity, Liverpool Partners, Insight, OneVentures, Bioscience Managers, Clean Energy Finance Corporation and Employment Hero.

Work highlights - Private Equity

Potentia Capital 

Take-private acquisition of Nitro Software (ASX:NTO), its acquisitions of Micromine, SuperChoice Services, NewBook (as well as its sale), Commerce Vision and PC-EFTPOS and its investments in Soprano Design and EstimateOne.

Advent International 

Acquisition of a majority stake in the Australian luxury fashion brand ZIMMERMANN, which operates retail stores in Australia, the US, UK, Europe and China, as well as being represented in prestigious department stores and luxury retailers worldwide. 

Archer Capital

Sale of illion to Experian, its divestment of V8 Supercars to RACE, partial divestment of illion (formerly Dunn & Bradstreet) to Macquarie and its divestment of LCR Group to Qube Holdings.

Liverpool Partners

Divestment of Biomedx, its investment in Baby Village, its acquisitions of Genea, Adora Fertility, Simplyai and of Melbourne IT Consultancy, Seisma, the portfolio acquisitions by Seisma of coIB, Smart Apps, Braestone and Data Addiction, the portfolio acquisition by Genea Fertility of Fertility SA and its convertible note investment in HealthEngine.

Accel-KKR 

Acquisition of IntelliHR Limited (ASX:IHR), by its portfolio company Humanforce, by way of scheme of arrangement and subsequently by way of a contested takeover bid and on Series A investments in Pegasus Management and Humanforce.

EQT

Acquisition of VetPartners, the leading provider of veterinary and animal health services in Australia and New Zealand. 

Work highlights - Growth Equity / Venture Capital

OneVentures

Investments in ImmVirx, BiVACOR and Vaxxas.

Cardiac Dimensions

Convertible note financings and Series B, C and D financings.

Insight Partners and Insight Venture Capital 

Investments in Employment Hero, SafetyCulture, Linktree, EQL Launches, Devicie, Octopus Deploy and Relevance AI. 

Unilever Ventures

Series A investments in Growth Alchemist and Frank Body.

Clean Energy Finance Corporation

Investments in H2Lab and Xefco and its Series B, C and D capital raisings in Sunman Energy.

Protecht Group Holdings

Investment in Protecht by Arrowroot Capital.

Technology, Media and Telecoms M&A Legal Advisor of the Year, 2023

Mergermarket

Finalist - Transaction Team of the Year, 2024

Lawyers Weekly

"A highly capable team with significant capital markets knowledge and experience. There is a significant level of engagement from partners to junior resources on projects which ensures a consistent quality of work, and tight deadlines are met."

Chambers & Partners

"Strong technical and commercial advice was provided on all deal aspects, with 100% reliability and responsiveness."

Chambers & Partners

"There is always plenty of depth to deal with peak workload and high-quality output, they are very responsive and can always be reached, with deadlines always achieved."

Chambers & Partners

ZIMMERMANN (Advent International) transaction announced winner of Private Equity Deal of the Year, Mergermarket M&A Awards Australia 2024

Mergermarket
1/6